1. Home
  2. BVS vs GEVO Comparison

BVS vs GEVO Comparison

Compare BVS & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • GEVO
  • Stock Information
  • Founded
  • BVS 2011
  • GEVO 2005
  • Country
  • BVS United States
  • GEVO United States
  • Employees
  • BVS N/A
  • GEVO N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GEVO Major Chemicals
  • Sector
  • BVS Health Care
  • GEVO Industrials
  • Exchange
  • BVS Nasdaq
  • GEVO Nasdaq
  • Market Cap
  • BVS 883.7M
  • GEVO 749.5M
  • IPO Year
  • BVS 2021
  • GEVO 2011
  • Fundamental
  • Price
  • BVS $11.24
  • GEVO $1.43
  • Analyst Decision
  • BVS Strong Buy
  • GEVO Strong Buy
  • Analyst Count
  • BVS 2
  • GEVO 3
  • Target Price
  • BVS $16.00
  • GEVO $6.48
  • AVG Volume (30 Days)
  • BVS 489.1K
  • GEVO 9.3M
  • Earning Date
  • BVS 11-05-2024
  • GEVO 11-07-2024
  • Dividend Yield
  • BVS N/A
  • GEVO N/A
  • EPS Growth
  • BVS N/A
  • GEVO N/A
  • EPS
  • BVS N/A
  • GEVO N/A
  • Revenue
  • BVS $555,061,000.00
  • GEVO $15,589,000.00
  • Revenue This Year
  • BVS $11.24
  • GEVO $18.65
  • Revenue Next Year
  • BVS $6.77
  • GEVO $56.15
  • P/E Ratio
  • BVS N/A
  • GEVO N/A
  • Revenue Growth
  • BVS 10.40
  • GEVO 16.59
  • 52 Week Low
  • BVS $3.67
  • GEVO $0.48
  • 52 Week High
  • BVS $14.38
  • GEVO $3.39
  • Technical
  • Relative Strength Index (RSI)
  • BVS 41.28
  • GEVO 36.21
  • Support Level
  • BVS $7.30
  • GEVO $1.41
  • Resistance Level
  • BVS $12.61
  • GEVO $1.72
  • Average True Range (ATR)
  • BVS 0.97
  • GEVO 0.23
  • MACD
  • BVS -0.25
  • GEVO -0.15
  • Stochastic Oscillator
  • BVS 55.65
  • GEVO 1.96

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.

Share on Social Networks: